60 DEGREES PHARMACEUTICALS INC
For the period ended Mar 31, 2024. Filed May 15, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 15, 2024
SXTP$0.52-4.7%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Condensed Statements of Cash Flows
CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS (UNAUDITED)
| For the Three Months Ended March 31, · 2024 · 2023 | ||||
|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||
| Net Income (Loss) | $427,985 | $(2,597,534) | ||
| Adjustments to Reconcile Net Income (Loss) to Net Cash Used in Operating Activities: | ||||
| Depreciation | 407 | 6,901 | ||
| Amortization | 8,207 | 7,175 | ||
| Amortization of Debt Discount | - | 343,510 | ||
| Amortization of ROU Asset | 13,517 | 12,427 | ||
| Amortization of Note Issuance Costs | - | 31,757 | ||
| Amortization of Capitalized Share-Based Payments | 125,368 | 320,825 | ||
| Share-Based Compensation to Vendors for Services | - | 212,605 | ||
| Loss on Debt Extinguishment | - | 839,887 | ||
| Change in Fair Value of Derivative Liabilities | (1,740,847) | 5,134 | ||
| Change in Fair Value of Promissory Note | - | (339,052) | ||
| Write-offs of Capitalized Patents | 8,378 | - | ||
| Inventory Reserve | - | 4,205 | ||
| Changes in Operating Assets and Liabilities: | ||||
| Accounts Receivable | (84,888) | (36,890) | ||
| Prepaid and Other Assets | 61,841 | 18,020 | ||
| Inventory | 30,792 | (108,082) | ||
| Accounts Payable and Accrued Liabilities | 23,243 | 77,038 | ||
| Accrued Interest | (791) | 761,643 | ||
| Reduction of Lease Liability | (13,650) | (12,247) | ||
| Deferred Compensation | - | 40,000 | ||
| Net Cash Used in Operating Activities | (1,140,438) | (412,678) | ||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||
| Capitalization of Patents | (726) | (3,292) | ||
| Acquisition of Intangibles | (9,088) | - | ||
| Net Cash Used in Investing Activities | (9,814) | (3,292) | ||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||
| Net Proceeds from Common Stock and Warrants Offering | 1,914,513 | - | ||
| Payment of Deferred Offering Costs | (16,217) | (17,612) | ||
| Proceeds from Exercise of Pre-Funded Warrants | 4,995 | - | ||
| Proceeds from Advances - Related Party | - | 200,000 | ||
| Net Cash Provided by Financing Activities | 1,903,291 | 182,388 | ||
| Effect of Exchange Rate Changes on Cash | (824) | (1,290) | ||
| Change in Cash | 752,215 | (234,872) | ||
| Cash—Beginning of Period | 2,142,485 | 264,865 | ||
| Cash—End of Period | $2,894,700 | $29,993 | ||
| NONCASH INVESTING/FINANCING ACTIVITIES | ||||
| Capitalized Share-Based Payments to Vendors | $ | - | $4,908,658 | |
| Fair Value of Warrants Issued to Underwriters | $71,364 | $ | - | |
| Additions to ROU Assets for Lease Renewal | $ | - | $50,922 | |
| Additions to Lease Liabilities for Lease Renewal | $ | - | $50,570 | |
| Stock Issued for Payment of Deferred Compensation | $ | - | $325,000 | |
| Stock Issued for Acquisition of Intangibles | $ | - | $33,895 | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.